A scan to diagnose or monitor disease
Part of Cancer, Lungs & breathing clinical trials.
This study uses a special scan (PET/CT) with a safe radioactive tracer to help doctors look for or track conditions like cancer, brain problems, or heart issues. It may help get clearer answers for your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to have a known or suspected illness like cancer, memory problems, seizures, or heart disease.
- You must be able to give permission (or have a caregiver do it) and follow the scan instructions.
- You need to be able to lie still for the scan and handle the waiting time.
- You must not be pregnant or, if breastfeeding, be willing to pause for 12 hours.
- Your weight must be under 500 lbs (227 kg) for the scanner bed.
- You must not be too anxious (like claustrophobia) to go through with the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This trial uses a special PET scan to see how well it can find and track different types of cancer. It may help doctors better understand your cancer.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.